Anatomic Stage IV Breast Cancer AJCC v8 Completed Phase 2 Trials for Imatinib (DB00619)

IndicationStatusPhase
DBCOND0109665 (Anatomic Stage IV Breast Cancer AJCC v8)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00338728Letrozole and Imatinib Mesylate in Treating Postmenopausal Participants With Estrogen or Progesterone Positive Metastatic Breast CancerTreatment